Resistance mutations of NS3 and NS5b in treatment-naïve patients infected with hepatitis C virus in Santa Catarina and Rio Grande do Sul states, Brazil

Hepatitis C virus (HCV) infection is a worldwide health problem. Nowadays, direct-acting antiviral agents (DAAs) are the main treatment for HCV; however, the high level of virus variability leads to the development of resistance-associated variants (RAVs). Thus, assessing RAVs in infected patients i...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade, Elisabete, Rocha, Daniele, Fontana-Maurell, Marcela, Costa, Elaine, Ribeiro, Marisa, de Godoy, Daniela Tupy, Ferreira, Antonio G.P., Tanuri, Amilcar, Brindeiro, Rodrigo, Alvarez, Patrícia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Genética 2020
Materias:
Human and Medical Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229887/
https://www.ncbi.nlm.nih.gov/pubmed/31644681
http://dx.doi.org/10.1590/1678-4685-GMB-2018-0237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229887/
https://www.ncbi.nlm.nih.gov/pubmed/31644681
http://dx.doi.org/10.1590/1678-4685-GMB-2018-0237

Ejemplares similares